X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15) 15
index medicus (15) 15
female (13) 13
adult (9) 9
cancer (9) 9
health aspects (8) 8
middle aged (8) 8
oncology (8) 8
papillomavirus infections (8) 8
papillomavirus infections - prevention & control (8) 8
womens health (8) 8
analysis (7) 7
cervical cancer (7) 7
internal medicine (7) 7
prevention (7) 7
research (7) 7
uterine cervical neoplasms - prevention & control (7) 7
abridged index medicus (6) 6
cervical intraepithelial neoplasia - prevention & control (6) 6
clinical trials (6) 6
double-blind method (6) 6
human papillomavirus (6) 6
medicine, general & internal (6) 6
oncology, experimental (6) 6
uterine cervical neoplasms - virology (6) 6
vaccines (6) 6
women (6) 6
hematology, oncology and palliative medicine (5) 5
human papillomavirus 16 - immunology (5) 5
human papillomavirus 18 - immunology (5) 5
intraepithelial neoplasia (5) 5
papillomavirus vaccines - administration & dosage (5) 5
adjuvants, immunologic - administration & dosage (4) 4
cervical intraepithelial neoplasia - virology (4) 4
chemotherapy (4) 4
dna, viral - analysis (4) 4
endometrial cancer (4) 4
follow-up (4) 4
papillomaviruses (4) 4
studies (4) 4
uterine cervical neoplasms - pathology (4) 4
young-women (4) 4
adolescent (3) 3
age (3) 3
aged (3) 3
australia (3) 3
cervical intraepithelial neoplasia - pathology (3) 3
dna (3) 3
europe (3) 3
follow-up studies (3) 3
human papillomavirus 16 - genetics (3) 3
human papillomavirus 18 - genetics (3) 3
medical colleges (3) 3
medical screening (3) 3
metaanalysis (3) 3
neoplasm grading (3) 3
north america (3) 3
papillomavirus infections - diagnosis (3) 3
papillomavirus infections - epidemiology (3) 3
papillomavirus infections - virology (3) 3
papillomavirus vaccines - immunology (3) 3
particle vaccine (3) 3
public health (3) 3
risk factors (3) 3
treatment outcome (3) 3
uterine cervical neoplasms - diagnosis (3) 3
uterine cervical neoplasms - epidemiology (3) 3
vaccination (3) 3
young adult (3) 3
aluminum hydroxide - administration & dosage (2) 2
asia (2) 2
broad-spectrum (2) 2
carboplatin - administration & dosage (2) 2
carcinoma (2) 2
carcinoma patients (2) 2
cellular biology (2) 2
cervical intraepithelial neoplasia - diagnosis (2) 2
cervical intraepithelial neoplasia - epidemiology (2) 2
controlled-trial (2) 2
cross infection (2) 2
cross reactions (2) 2
cytology (2) 2
decision making (2) 2
diagnosis (2) 2
early detection of cancer (2) 2
epitopes (2) 2
health care sciences & services (2) 2
hpv vaccination (2) 2
human medicine (2) 2
human papillomavirus 16 - pathogenicity (2) 2
human papillomavirus 18 - pathogenicity (2) 2
human-papillomavirus (2) 2
human-papillomavirus infection (2) 2
iii trial (2) 2
immunization (2) 2
implementation (2) 2
infection (2) 2
infections (2) 2
invasive cervical-cancer (2) 2
lesions (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9895, pp. 889 - 899
Summary Cervical cancer is caused by human papillomavirus infection. Most human papillomavirus infection is harmless and clears spontaneously but persistent... 
Internal Medicine | WOMEN | POPULATION | MEDICINE, GENERAL & INTERNAL | PERSISTENCE | DNA | VACCINE | HPV INFECTION | FOLLOW-UP | RISK | CYTOLOGY | INTRAEPITHELIAL NEOPLASIA | Human papillomavirus 18 - immunology | Human papillomavirus 6 - immunology | Humans | Uterine Cervical Neoplasms - epidemiology | Human papillomavirus 11 - ultrastructure | Uterine Cervical Neoplasms - pathology | Human papillomavirus 16 - immunology | Human papillomavirus 6 - ultrastructure | Papillomavirus Infections - pathology | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Human papillomavirus 11 - immunology | Human papillomavirus 16 - ultrastructure | Human papillomavirus 11 - pathogenicity | Papillomavirus Vaccines - administration & dosage | Human papillomavirus 6 - pathogenicity | Human papillomavirus 16 - pathogenicity | Cross-Sectional Studies | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Vaginal Smears | Mass Screening | Virus Replication | Human papillomavirus 18 - pathogenicity | Papillomavirus Infections - prevention & control | Uterine Cervical Neoplasms - virology | Human papillomavirus 18 - ultrastructure | Papillomavirus Vaccines - immunology | Developing Countries | Cell Transformation, Neoplastic - pathology | Cell Transformation, Viral | Prevention | Papillomaviruses | Usage | Vaccines | Properties | Papillomavirus infections | Risk factors | Cervical cancer | Studies | Human papillomavirus | Immunization | Cellular biology | Womens health | Medical screening | Epidemiology | Age
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. 1114 - 1126
Summary Background About 15% of patients with endometrial cancer have high-risk features and are at increased risk of distant metastases and endometrial... 
Hematology, Oncology and Palliative Medicine | CARCINOMA PATIENTS | EXTERNAL-BEAM RADIOTHERAPY | GYNECOLOGIC-ONCOLOGY-GROUP | ONCOLOGY | PELVIC RADIATION-THERAPY | EUROPEAN-ORGANIZATION | STAGE-I | OVARIAN-CANCER | INTERMEDIATE-RISK | III TRIAL | CHEMOTHERAPY | Endometrial Neoplasms - radiotherapy | Prognosis | Follow-Up Studies | Humans | Middle Aged | Gastrointestinal Diseases - etiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Adenocarcinoma, Clear Cell - radiotherapy | Chemoradiotherapy, Adjuvant - adverse effects | Nervous System Diseases - diagnosis | Case-Control Studies | Gastrointestinal Diseases - diagnosis | Cisplatin - administration & dosage | Neoplasm Grading | Radiotherapy, Adjuvant - adverse effects | Cystadenocarcinoma, Serous - therapy | Female | Paclitaxel - administration & dosage | Cystadenocarcinoma, Serous - secondary | Neoplasm Invasiveness | Carboplatin - administration & dosage | Survival Rate | Lymphatic Metastasis | Hematologic Diseases - diagnosis | Adenocarcinoma, Clear Cell - secondary | Hematologic Diseases - etiology | Adenocarcinoma, Clear Cell - therapy | Endometrial Neoplasms - therapy | Nervous System Diseases - etiology | Quality of Life | Endometrial Neoplasms - pathology | Aged | Neoplasm Staging | Cystadenocarcinoma, Serous - radiotherapy | Endometrial cancer | Oncology, Experimental | Radiation | Metastasis | Research | Radiotherapy | Health aspects | Risk factors | Cancer
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9580, pp. 2161 - 2170
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 7, pp. 672 - 682
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 89 - 99
Summary Background Cervical intraepithelial neoplasia grade 2 or greater (CIN2+) is the surrogate endpoint used in licensure trials of human papillomavirus... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | PARTICLE VACCINE | ADENOCARCINOMA | HPV VACCINATION | FOLLOW-UP | TYPE-16 | YOUNG-WOMEN | CANCER | CARCINOMA | TRENDS | HUMAN-PAPILLOMAVIRUS INFECTION | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adenocarcinoma - pathology | Adjuvants, Immunologic - administration & dosage | Age Factors | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Time Factors | Adult | Female | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Adenocarcinoma - virology | Cervical Intraepithelial Neoplasia - virology | Adenocarcinoma - diagnosis | Adenocarcinoma - prevention & control | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Australia | Human papillomavirus 16 - genetics | Medical colleges | Care and treatment | Cervix dysplasia | Vaccination | Oncology, Experimental | Clinical trials | Vaccines | Research | Prevention | Sexually transmitted diseases | Analysis | Cross infection | Adults | Nosocomial infections | Children | Papillomavirus infections | Health aspects | Cervical cancer | Public health | Cancer
Journal Article